How has been the historical performance of Zenlabs Ethica?

Answer:The historical performance of Zenlabs Ethica shows a declining trend in net sales and profit over the past few years, with net sales decreasing from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. The total operating income followed a similar pattern, dropping from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. Operating profit (PBDIT) also saw fluctuations, peaking at 3.04 Cr in Mar'23 before falling to 2.61 Cr in Mar'25. Profit before tax decreased from 1.89 Cr in Mar'19 to 0.43 Cr in Mar'25, while profit after tax declined from 1.26 Cr in Mar'19 to 0.27 Cr in Mar'25. The earnings per share (EPS) reflected this downward trend, decreasing from 1.94 in Mar'19 to 0.41 in Mar'25.

In terms of assets and liabilities, total assets increased from 33.65 Cr in Mar'20 to 40.38 Cr in Mar'25, while total liabilities also rose from 31.75 Cr in Mar'21 to 40.38 Cr in Mar'25. The company maintained a consistent share capital of 6.51 Cr over the years, and reserves grew from 0.90 Cr in Mar'20 to 3.92 Cr in Mar'25. Cash flow from operating activities improved to 3.00 Cr in Mar'25 from a negative 9.00 Cr in Mar'24, indicating a recovery in operational cash generation. Overall, while Zenlabs Ethica has experienced challenges in revenue and profit, there are signs of improvement in cash flow from operations.

Breakdown:
Zenlabs Ethica's financial performance has shown a notable decline in net sales, which fell from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25, reflecting a consistent downward trend over the years. Total operating income mirrored this decline, decreasing from 69.09 Cr to 51.42 Cr in the same period. Operating profit (PBDIT) peaked at 3.04 Cr in Mar'23 but subsequently dropped to 2.61 Cr in Mar'25. Profit before tax also decreased significantly from 1.89 Cr in Mar'19 to 0.43 Cr in Mar'25, while profit after tax fell from 1.26 Cr to 0.27 Cr over the same timeframe. Earnings per share (EPS) declined from 1.94 in Mar'19 to 0.41 in Mar'25, indicating reduced profitability for shareholders. On the balance sheet, total assets increased from 33.65 Cr in Mar'20 to 40.38 Cr in Mar'25, alongside a rise in total liabilities from 31.75 Cr to 40.38 Cr. The company maintained a stable share capital of 6.51 Cr and saw its reserves grow from 0.90 Cr to 3.92 Cr. Notably, cash flow from operating activities improved to 3.00 Cr in Mar'25, recovering from a negative 9.00 Cr in Mar'24, suggesting a positive shift in operational cash generation despite the overall challenges in revenue and profit.